stella
beta
To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function — Stella
Recruiting
Back to Diabetes Mellitus, Type 2 trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
South Korea
Seoul National University Hospital, Seoul
View full record on ClinicalTrials.gov